PillEverolimus
Brands: Afinitor · Torpenz · Yulithira · Zortress · Everolimus
12 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 39 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it12 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Biocon Pharma Inc | unknown | 20 | SUPPLYING |
| Natco Pharma Limited | unknown | 16 | SUPPLYING |
| Novugen Pharma (USA) LLC. | unknown | 12 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 8 | SUPPLYING |
| Breckenridge Pharmaceutical, Inc. | unknown | 8 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 8 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 8 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 8 | SUPPLYING |
| Par Health USA, LLC | unknown | 7 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 4 | SUPPLYING |
| CivicaScript LLC | unknown | 4 | SUPPLYING |
| NorthStar RxLLC | unknown | 4 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 2, 2026RESOLVEDShortage resolved: Everolimus Tablet (Teva Pharmaceuticals USA, Inc.)
Everolimus Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Transplant.
- Mar 2, 2026SHORTAGEDrug shortage: Everolimus Tablet (Teva Pharmaceuticals USA, Inc.)
Everolimus Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Transplant.
- Jan 6, 2026RESOLVEDShortage resolved: Everolimus Tablet (Endo Pharmaceuticals, Inc.)
Everolimus Tablet — reported in shortage by Endo Pharmaceuticals, Inc.. Therapeutic category: Transplant.
- Jan 6, 2026SHORTAGEDrug shortage: Everolimus Tablet (Endo Pharmaceuticals, Inc.)
Everolimus Tablet — reported in shortage by Endo Pharmaceuticals, Inc.. Therapeutic category: Transplant.
- Oct 10, 2025RECALLRecall (Class III): Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured…
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Recalling firm: Endo USA, Inc. — Nationwide within the United States
- Oct 10, 2025RECALLRecall (Class III): Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufacture…
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Recalling firm: Endo USA, Inc. — Nationwide within the United States
- Oct 10, 2025RECALLRecall (Class III): Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured b…
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Recalling firm: Endo USA, Inc. — Nationwide within the United States
- Oct 10, 2025RECALLRecall (Class III): Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured…
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Recalling firm: Endo USA, Inc. — Nationwide within the United States
- Sep 5, 2025RECALLRecall (Class III): Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured b…
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. — Recalling firm: Endo USA, Inc. — Nationwide within the United States